208 related articles for article (PubMed ID: 26629605)
1. [Psychotropic drug prescription to people with intellectual disability in GP practices].
Bakker-van Gijssel EJ; Leusink GL
Ned Tijdschr Geneeskd; 2015; 159():A9754. PubMed ID: 26629605
[TBL] [Abstract][Full Text] [Related]
2. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
[TBL] [Abstract][Full Text] [Related]
3. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population.
Axmon A; El Mrayyan N; Eberhard J; Ahlström G
BMC Psychiatry; 2019 Aug; 19(1):238. PubMed ID: 31370823
[TBL] [Abstract][Full Text] [Related]
5. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability].
de Kuijper G; Degraeve G; Zinkstok JR
Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889
[TBL] [Abstract][Full Text] [Related]
6. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
de Kuijper GM; Hoekstra PJ
J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
[No Abstract] [Full Text] [Related]
8. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
Paton C; Bhatti S; Purandare K; Roy A; Barnes T
BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
[TBL] [Abstract][Full Text] [Related]
9. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
[TBL] [Abstract][Full Text] [Related]
10. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
Mark TL
CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic drug prescribing in child and adolescent learning disability psychiatry.
Bramble D
J Psychopharmacol; 2007 Jul; 21(5):486-91. PubMed ID: 17446203
[TBL] [Abstract][Full Text] [Related]
12. Use of psychotropic medication in people with a learning disability.
Jenkins R
Br J Nurs; 2000 Jul 13-26; 9(13):844-50. PubMed ID: 11261057
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
14. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
[TBL] [Abstract][Full Text] [Related]
16. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
[TBL] [Abstract][Full Text] [Related]
17. Trends in GP prescribing of psychotropic medications among young patients aged 16-24 years: a case study analysis.
Brijnath B; Xia T; Turner L; Mazza D
BMC Psychiatry; 2017 Jun; 17(1):214. PubMed ID: 28587610
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
19. Trends in antipsychotic drug use by very young, privately insured children.
Olfson M; Crystal S; Huang C; Gerhard T
J Am Acad Child Adolesc Psychiatry; 2010 Jan; 49(1):13-23. PubMed ID: 20215922
[TBL] [Abstract][Full Text] [Related]
20. Prescribing Patterns of Psychotropic Drugs and Risk of Violent Behavior: A Prospective, Multicenter Study in Italy.
di Giacomo E; Stefana A; Candini V; Bianconi G; Canal L; Clerici M; Conte G; Ferla MT; Iozzino L; Sbravati G; Tura G; Micciolo R; de Girolamo G;
Int J Neuropsychopharmacol; 2020 May; 23(5):300-310. PubMed ID: 31993630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
